Τετάρτη 26 Ιουλίου 2017

Targeted therapy for brain and CNS tumours

Dr Fidler speaks with ecancer at NOSCM 2017 about treating brain and central nervous system cancers with EGFR and ALK mutations. She describes how results from small phase I trials are providing useful insights into rare or relapsed diseases, and...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2h2rHu3
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις